Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hamza Al-madani"'
Autor:
Mohammed Safi, Mahmoud Al-Azab, Chenxing Jin, Dario Trapani, Salem Baldi, Salah Adlat, Aman Wang, Bashir Ahmad, Hamza Al-madani, Xiu Shan, Jiwei Liu
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Immune checkpoint inhibitors (ICIs) have revolutionized metastatic melanoma treatment, but our knowledge of ICI activity across age groups is insufficient. Patients in different age groups with advanced melanoma were selected based on the ICI approva
Externí odkaz:
https://doaj.org/article/e3bbedb1cd5b45c9be422cb26d540dfe
Autor:
Salah Adlat, Mohammed Safi, Mahmoud Al-Azab, Aman Wang, Chenxing Jin, Salem Baldi, Hamza Al-madani, Bashir Ahmad, Dario Trapani, Xiu Shan, Jiwei Liu
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Immune checkpoint inhibitors (ICIs) have revolutionized metastatic melanoma treatment, but our knowledge of ICI activity across age groups is insufficient. Patients in different age groups with advanced melanoma were selected based on the ICI approva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::255899e38434d87951e921d356507d94
https://www.frontiersin.org/articles/10.3389/fimmu.2021.609728/full
https://www.frontiersin.org/articles/10.3389/fimmu.2021.609728/full
Autor:
Mohammed, Safi, Mahmoud, Al-Azab, Chenxing, Jin, Dario, Trapani, Salem, Baldi, Salah, Adlat, Aman, Wang, Bashir, Ahmad, Hamza, Al-Madani, Xiu, Shan, Jiwei, Liu
Publikováno v:
Frontiers in Immunology
Immune checkpoint inhibitors (ICIs) have revolutionized metastatic melanoma treatment, but our knowledge of ICI activity across age groups is insufficient. Patients in different age groups with advanced melanoma were selected based on the ICI approva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f5432928e87d3848e0dddb0f4dd73435
https://pubmed.ncbi.nlm.nih.gov/34887846
https://pubmed.ncbi.nlm.nih.gov/34887846